Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer

This study is currently recruiting participants.

Verified January 2013 by Asan Medical Center

Study NCT01471470 Information provided by Asan Medical Center

First Received on July 18, 2011. Last Updated on January 10, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

Stomach Neoplasms

More general conditions related to this trial

Additional drug interventions recognized in this trial

Bevacizumab
Capecitabine
Cisplatin
Docetaxel

More general drug interventions related to this trial

Sponsors listed in this trial